Long-term safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 8-year results from the ACHIEVE study
A significant BP reduction was observed up until 8 years following uRDN in parallel to a decrease in drug burden over time, in the absence of procedure-related adverse events.
Authors
- Sebastian Völz (ORCID: https://orcid.org/0000-0002-9609-5360)
- Mattie Lenzen (ORCID: https://orcid.org/0000-0002-2292-3258)
- Joost Daemen (ORCID: https://orcid.org/0000-0001-8628-1410)
- Karl‐Heinz Kück (ORCID: https://orcid.org/0000-0003-2649-3870)
- Philipp Kahlert
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Michael Kunz (ORCID: https://orcid.org/0000-0001-9666-2209)
- Isabella Kardys (ORCID: https://orcid.org/0000-0002-2115-9745)
- Tobias Graf (ORCID: https://orcid.org/0000-0003-4038-147X)
- Thomas Zeller (ORCID: https://orcid.org/0000-0003-2704-3871)
- Victor Zeijen (ORCID: https://orcid.org/0000-0003-0029-4064)
- Meital Horesh-Bar
- Bert Andersson (ORCID: https://orcid.org/0000-0001-7957-2463)
- Horst Sievert
Institutions
- Sahlgrenska University Hospital (SE)
- Erasmus MC (NL)
- University Hospital Schleswig-Holstein (DE)
- Cardiovascular Center Frankfurt (DE)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
- West German Heart and Vascular Center Essen (DE)
- Erasmus University Rotterdam (NL)
- Saarland University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1007/s00392-024-02555-7
- Citations
- 5
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- ReCor Medical